Tumor necrosis factor (TNF; also termed TNF--alpha or cachectin) is a multifunctional cytokine whose biological activities -- in addition to its demonstrated ability to inhibit tumor growth in animals -- include regulatory effects on the synthess of many cellular proteins, inhibitory or stimulatory actions on cell growth, and inhibitory actions on the replications of viruses. Our long-term goal is to obtain a better understanding of the physiological, pathophysiological and host defense functions of TNF, and to elucidate the molecular mechanisms of its important actions. Our studies should also help to better understand the potential and the limitations of TNF as a biological response modifier and antitumor agent. In our present proposal we are seeking a better understanding of TNF's ability to act either as a mitogenic agent or cell growth inhibitor in cultured cells. We shall analyze controlled, standardized conditions. In analyzing TNF's growth-promoting activity in human and murine fibroblasts we shall attempt to determine whether the mitogenic action (a) is due to a direct activation cellular functions promoting quiescent cells to enter and traverse the cell cycle, (b) is due to an induction of cellular responsiveness to extraneous growth factors, and/or (c) occurs via the release of other autocrine growth factor(s) by target cells. In parallel, we shall analyze TNF's ability to alter the expression of some cellular genes implicated in the regulation of cell growth and differentiation. Specifically, we shall analyze mechanisms whereby TNF produces activation of the proto-oncogenes c-fos and c-myc, and of the gene for a secreted protein provisionally termed interferon (IFN)-beta2/BSF-2, and we shall try to determine how the activation of c-fos, c-myc and the IFN- beta2/BSF-2 genes may be related to TNF's ability to stimulate or inhibit cell growth.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA047304-02
Application #
3190855
Study Section
Cellular Biology and Physiology Subcommittee 1 (CBY)
Project Start
1988-04-01
Project End
1993-03-31
Budget Start
1989-04-01
Budget End
1990-03-31
Support Year
2
Fiscal Year
1989
Total Cost
Indirect Cost
Name
New York University
Department
Type
Schools of Medicine
DUNS #
004514360
City
New York
State
NY
Country
United States
Zip Code
10012
Lee, T H; Wisniewski, H G; Vilcek, J (1992) A novel secretory tumor necrosis factor-inducible protein (TSG-6) is a member of the family of hyaluronate binding proteins, closely related to the adhesion receptor CD44. J Cell Biol 116:545-57
Vilcek, J; Palombella, V J (1992) TNF as a growth factor. Immunol Ser 56:269-87
Vilcek, J; Lee, T H (1991) Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions. J Biol Chem 266:7313-6
Gase, K; Korobko, V G; Wisniewski, H G et al. (1990) Critical role of the C-terminus in the biological activities of human tumour necrosis factor-alpha. Immunology 71:368-71
Zhang, Y H; Lin, J X; Vilcek, J (1990) Interleukin-6 induction by tumor necrosis factor and interleukin-1 in human fibroblasts involves activation of a nuclear factor binding to a kappa B-like sequence. Mol Cell Biol 10:3818-23
Aderka, D; Le, J M; Vilcek, J (1989) IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice. J Immunol 143:3517-23
Palombella, V J; Vilcek, J (1989) Mitogenic and cytotoxic actions of tumor necrosis factor in BALB/c 3T3 cells. Role of phospholipase activation. J Biol Chem 264:18128-36
Reis, L F; Ho Lee, T; Vilcek, J (1989) Tumor necrosis factor acts synergistically with autocrine interferon-beta and increases interferon-beta mRNA levels in human fibroblasts. J Biol Chem 264:16351-4
Le, J M; Fredrickson, G; Pollack, M et al. (1989) Activation of thymocytes and T cells by interleukin-6. Ann N Y Acad Sci 557:444-52;discussion 452-3
Zhang, Y H; Lin, J X; Yip, Y K et al. (1988) Enhancement of cAMP levels and of protein kinase activity by tumor necrosis factor and interleukin 1 in human fibroblasts: role in the induction of interleukin 6. Proc Natl Acad Sci U S A 85:6802-5